BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31053176)

  • 21. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
    Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The TREX2 3'-->5' exonuclease physically interacts with DNA polymerase delta and increases its accuracy.
    Shevelev IV; Ramadan K; Hübscher U
    ScientificWorldJournal; 2002 Feb; 2():275-81. PubMed ID: 12806015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
    Chen X; Liu L; Mims J; Punska EC; Williams KE; Zhao W; Arcaro KF; Tsang AW; Zhou X; Furdui CM
    Epigenetics; 2015; 10(6):545-61. PubMed ID: 25961636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human TREX2 3' -> 5'-exonuclease structure suggests a mechanism for efficient nonprocessive DNA catalysis.
    Perrino FW; Harvey S; McMillin S; Hollis T
    J Biol Chem; 2005 Apr; 280(15):15212-8. PubMed ID: 15661738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues].
    Yang J; Ji WY; Qu YR; He LX; Zhao XD; Jin MZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):308-12. PubMed ID: 21624251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Susceptibility to Skin Carcinogenesis in TREX2 Knockout Mice.
    Parra D; Manils J; Castellana B; Viña-Vilaseca A; Morán-Salvador E; Vázquez-Villoldo N; Tarancón G; Borràs M; Sancho S; Benito C; Ortega S; Soler C
    Cancer Res; 2009 Aug; 69(16):6676-84. PubMed ID: 19654293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of O6-methylguanine-DNA methyltransferase gene promoter region methylation pattern using pyrosequencing and the effect of methylation pattern on survival, recurrence, and chemotherapy sensitivity in patients with laryngeal cancer.
    Onerci Celebi O; Tezel GG; Hosal AS; Cengiz M; Gullu IH; Hayran M
    Pathol Res Pract; 2016 May; 212(5):456-62. PubMed ID: 27067808
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of ST6GAL1 in human bladder cancer.
    Antony P; Rose M; Heidenreich A; Knüchel R; Gaisa NT; Dahl E
    BMC Cancer; 2014 Dec; 14():901. PubMed ID: 25465919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
    Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
    Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
    Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
    Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
    Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
    Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
    Rieke DT; Ochsenreither S; Klinghammer K; Seiwert TY; Klauschen F; Tinhofer I; Keilholz U
    Oncotarget; 2016 Nov; 7(46):75379-75393. PubMed ID: 27683114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TREX through Cutaneous Health and Disease.
    Mathers AR
    J Invest Dermatol; 2016 Dec; 136(12):2337-2339. PubMed ID: 27884288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
    Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
    Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
    Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
    J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
    Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.